Kilitch Drugs (India) Limited (BOM:524500)

Kilitch Drugs (India) Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	2,071	1,983	1,544	1,396	1,142	685.23
Revenue Growth (YoY)	13.85%	28.47%	10.58%	22.20%	66.71%	28.51%
Cost of Revenue	1,114	1,053	793.92	754.16	673.86	379.13
Gross Profit	956.89	930.05	749.8	641.83	468.49	306.11
Selling, General & Admin	355.01	312.74	239.66	231.58	117.14	97.23
Other Operating Expenses	307.54	302.66	262.1	234.61	234.96	156.1
Operating Expenses	689.01	638.08	526.82	493.27	368.33	264.76
Operating Income	267.87	291.97	222.98	148.56	100.16	41.34
Interest Expense	-57.18	-50.41	-59.29	-49.19	-11.98	-7.54
Interest & Investment Income	36	36	4.2	3.1	2.5	2.26
Earnings From Equity Investments	0	0	0.02	0.02	-0.02	-0.02
Currency Exchange Gain (Loss)	28.07	28.07	19.96	15.6	-2.29	9.76
Other Non Operating Income (Expenses)	20.76	7.93	0.22	0.59	2.62	1.8
EBT Excluding Unusual Items	295.53	313.57	188.09	118.69	90.98	47.59
Impairment of Goodwill	-8.43	-8.43	-8.43	-8.43	-8.43	-8.43
Gain (Loss) on Sale of Investments	39.6	39.6	13.89	9.88	13.59	12.03
Pretax Income	326.71	344.74	193.55	120.14	96.14	51.2
Income Tax Expense	74.52	95.34	57.79	37.32	34.01	13.53
Earnings From Continuing Operations	252.19	249.4	135.75	82.83	62.14	37.67
Minority Interest in Earnings	12.11	17.61	10.26	21.65	11.54	-0.96
Net Income	264.3	267.01	146.01	104.48	73.67	36.71
Net Income to Common	264.3	267.01	146.01	104.48	73.67	36.71
Net Income Growth	35.45%	82.86%	39.75%	41.82%	100.68%	336.00%
Shares Outstanding (Basic)	17	16	16	16	16	15
Shares Outstanding (Diluted)	17	16	16	16	16	15
Shares Change (YoY)	3.10%	0.96%	2.23%	0.10%	0.56%	0.37%
EPS (Basic)	15.95	16.60	9.17	6.71	4.73	2.37
EPS (Diluted)	15.94	16.60	9.17	6.71	4.73	2.37
EPS Growth	31.36%	81.10%	36.71%	41.76%	99.58%	334.09%
Free Cash Flow	-	-293.31	-79.85	-12.26	-24.19	93.61
Free Cash Flow Per Share	-	-18.24	-5.01	-0.79	-1.55	6.05
Gross Margin	46.20%	46.90%	48.57%	45.98%	41.01%	44.67%
Operating Margin	12.93%	14.72%	14.44%	10.64%	8.77%	6.03%
Profit Margin	12.76%	13.46%	9.46%	7.48%	6.45%	5.36%
Free Cash Flow Margin	-	-14.79%	-5.17%	-0.88%	-2.12%	13.66%
EBITDA	288.13	313.56	246.36	175.51	116.29	52.75
EBITDA Margin	13.91%	15.81%	15.96%	12.57%	10.18%	7.70%
D&A For EBITDA	20.25	21.59	23.38	26.96	16.13	11.41
EBIT	267.87	291.97	222.98	148.56	100.16	41.34
EBIT Margin	12.93%	14.72%	14.44%	10.64%	8.77%	6.03%
Effective Tax Rate	22.81%	27.66%	29.86%	31.06%	35.37%	26.43%
Revenue as Reported	2,195	2,095	1,589	1,425	1,171	711.91

Source: S&P Global Market Intelligence. Standard template. Financial Sources.